Ensuring Patient Impact In Advanced Therapy Logistics: A Conversation With Cryoport Systems' Experts

The logistics behind advanced therapies extend far beyond simply moving shipments from one location to another; they involve safeguarding the integrity of life-saving treatments and ensuring that patients receive these therapies without any compromise. After their insightful discussion at Advanced Therapies Week 2025, we had the opportunity to sit down with Aruna Mor, Chief Commercial Officer, and Mike Dybicz, Senior Vice President & Chief Product Development Officer at Cryoport Systems.

In this conversation, they shared their deep expertise on how Cryoport Systems places patient impact at the heart of its operations, prioritizing the protection and delivery of critical therapies at every stage of the supply chain. Their commitment to excellence in logistics and patient care exemplifies how Cryoport ensures treatments reach patients safely, efficiently, and with the utmost integrity.